8.8K Views
•
08:52 min
•
June 13th, 2018
DOI :
June 13th, 2018
•Rozdziały w tym wideo
0:04
Title
0:47
Differentiation of Li-Fraumeni Syndrome (LFS) Patient-derived Induced Pluripotent Stem Cell (iPSC) to Mesenchymal Stem Cell (MSC) (Days 0 - 28)
2:19
iPSC-derived MSC Maturation (Day 28 - 45) and Differentiation of LFS MSC to Osteoblasts (Day 0 - 24)
4:33
Xenograft In Vivo Tumorigenesis Model Setup
6:39
Results: Representative LFS MSC Differentiation
8:10
Conclusion
Powiązane Filmy
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
18.9K Views
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
13.8K Views
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
6.8K Views
A Melanoma Patient-Derived Xenograft Model
12.2K Views
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
8.5K Views
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10.3K Views
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
7.1K Views
Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
4.3K Views
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
2.7K Views
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
5.2K Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone